Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

vTv Therapeutics Inc. (VTVT)

1.74   -0.03 (-1.69%) 09-29 09:36
Open: 1.77 Pre. Close: 1.77
High: 1.77 Low: 1.74
Volume: 10,554 Market Cap: 124M
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. The company is headquartered in High Point, North Carolina and currently employs 52 full-time employees. The firm is engaged in the discovery and development of orally administered small molecule drug candidates. Its drug candidate for the treatment of Alzheimer's disease (AD) is azeliragon (TTP488), an orally administered, small molecule antagonist targeting the receptor for advanced glycation endproducts (RAGE), for which it has commenced patient enrollment in a Phase III clinical trial. Its type II diabetes drug candidates include TTP399, an orally administered, liver-selective glucokinase activator (GKA), for which it has completed enrollment in its Phase IIb clinical trial, and TTP273, an orally administered, non-peptide agonist that targets the glucagon-like peptide-1 receptor (GLP-1r), for which it began enrollment in a Phase II clinical trial. The company has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.773 - 1.781 1.781 - 1.789
Low: 1.699 - 1.709 1.709 - 1.718
Close: 1.754 - 1.77 1.77 - 1.785

Technical analysis

as of: 2020-09-28 4:38:48 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.35     One year: 2.62
Support: Support1: 1.65    Support2: 1.37
Resistance: Resistance1: 2.01    Resistance2: 2.24
Pivot: 1.87
Moving Average: MA(5): 1.79     MA(20): 1.88
MA(100): 2.40     MA(250): 2.15
MACD: MACD(12,26): -0.10     Signal(9): -0.10
Stochastic oscillator: %K(14,3): 16.49     %D(3): 20.56
RSI: RSI(14): 36.81
52-week: High: 4.23  Low: 1.35  Change(%): 21.2
Average Vol(K): 3-Month: 51365  10-Days: 62535

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
VTVT has closed above bottom band by 29.4%. Bollinger Bands are 29.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 24 Sep 2020
vTv Therapeutics Inc. (VTVT) Moves -3.21% Lower: These Numbers are Too Good to be True - News Daemon

Thu, 24 Sep 2020
vTv Therapeutics Inc. (NASDAQ:VTVT) is Waving the Bear Flag - The Oracle Dispatch

Wed, 23 Sep 2020
Why should you add vTv Therapeutics Inc. (VTVT) to your portfolio? - Marketing Sentinel

Wed, 23 Sep 2020
BUZZ-U.S. STOCKS ON THE MOVE-VTv Therapeutics Inc, SPI Energy Co Ltd, Carvana Co, Stich Fix Inc - Nasdaq

Wed, 23 Sep 2020
vTv Therapeutics Presents Additional Positive Clinical Study Results Supporting the Safety and Efficacy of TTP399 as Adjunctive Therapy in Patients with Type 1 Diabetes - GlobeNewswire

Tue, 22 Sep 2020
Is vTv Therapeutics Inc (VTVT) The Right Choice in Biotechnology? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 48
Shares Float (M) 13
% Held by Insiders 76.63
% Held by Institutions 1.99
Shares Short (K) 1,900
Shares Short P. Month (K) 1,760

Stock Financials

EPS -0.433
EPS Est This Year -1.060
EPS Est Next Year -2.250
Book Value (p.s.) -1.450
Profit Margin
Operating Margin -98534.78
Return on Assets (ttm) -143.8
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.) -0.258
Sales Per Share
EBITDA (p.s.) -0.471
Qtrly Earnings Growth
Operating Cash Flow (M) -22
Levered Free Cash Flow (M) -13

Stock Valuations

PE Ratio -4.09
PEG Ratio
Price to Book value -1.22
Price to Sales 3690.83
Price to Cash Flow -3.78

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.